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Abstract
Background: Malaria microscopy, while the gold standard for malaria diagnosis, has limitations. Efficacy estimates in
drug and vaccine malaria trials are very sensitive to small errors in microscopy endpoints. This fact led to the
establishment of a Malaria Diagnostics Centre of Excellence in Kisumu, Kenya. The primary objective was to ensure valid
clinical trial and diagnostic test evaluations. Key secondary objectives were technology transfer to host countries,
establishment of partnerships, and training of clinical microscopists.
Case description: A twelve-day "long" and a four-day "short" training course consisting of supervised laboratory
practicals, lectures, group discussions, demonstrations, and take home assignments were developed. Well characterized
slides were developed and training materials iteratively improved. Objective pre- and post-course evaluations consisted
of 30 slides (19 negative, 11 positive) with a density range of 50–660 parasites/μl, a written examination (65 questions),
a photographic image examination (30 images of artifacts and species specific characteristics), and a parasite counting
examination.
Discussion and Evaluation: To date, 209 microscopists have participated from 11 countries. Seventy-seven
experienced microscopists participated in the "long" courses, including 47 research microscopists. Sensitivity improved
by a mean of 14% (CI 9–19%) from 77% baseline (CI 73–81 %), while specificity improved by a mean of 17% (CI 11–23%)
from 76% (CI 70–82%) baseline. Twenty-three microscopists who had been selected for a four-day refresher course
showed continued improvement with a mean final sensitivity of 95% (CI 91–98%) and specificity of 97% (CI 95–100%).
Only 9% of those taking the pre-test in the "long" course achieved a 90% sensitivity and 95% specificity, which increased
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to 61% of those completing the "short" course. All measures of performance improved substantially across each of the
five organization types and in each course offered.
Conclusion: The data clearly illustrated that false positive and negative malaria smears are a serious problem, even with
research microscopists. Training dramatically improved performance. Quality microscopy can be provided by the Centre
of Excellence concept. This concept can be extended to other diagnostics of public health importance, and
comprehensive disease control strategies.
Background
Quality of laboratory medicine has always been a barrier
to effective health care in the developing world. The issues
and potential solutions have been recently illustrated by
Petti, Bates and colleagues [1,2]. Laboratory end points
are a challenge in clinical trials in this setting as well.
Malaria microscopy remains the reference or "gold" stand-
ard for malaria diagnosis in clinical trials (drug and vac-
cine), new diagnostic methodology evaluation, and for
clinical care for much of the world today. It is known that
microscopy is an imperfect gold standard [3-5]. The accu-
racy of microscopy relates to innate ability, training, expe-
rience, motivation and laboratory resources.
New diagnostic methods are now available, including
malaria rapid diagnostic tests (RDTs) and PCR [3,5,6];
however, neither are yet validated in the clinical trial set-
ting. RDTs are coming into widespread clinical use in
some parts of the world, and they may well become key to
malaria management and control in many settings. Cur-
rently available devices have limitations, such as batch-to-
batch quality variation, species and density determina-
tion, persistent positivity, accuracy and cost [6]. Also of
concern with RDTs are the reported false negative results
in the presence of high parasitaemia [6]. The usefulness of
RDTs in higher transmission areas of Africa remains to be
determined, and comparative cost effectiveness studies
are needed.
Sensitivity and specificity of the new diagnostic tech-
niques have been evaluated based on microscopy. Varia-
bility in the accuracy of microscopy certainly accounts for
some of the wide spectrum of reported sensitivity and spe-
cificity of these new devices [5-7]. Because of various lim-
itations of new methods, microscopy will continue to
have a significant role in the clinical trial setting for several
years to come, and as the reference standard to which new
diagnostic devices are compared. Expert microscopy
should be available not only in reference centers, but also
in clinical trial sites worldwide.
Errors with microscopy and the need for uniform training,
quality assurance, and standardized reporting methods
have been noted in the literature [8,9]. A recent workshop
in Malaysia details the problem and outlines methods for
achieving quality with malaria microscopy [10]. Accuracy
improvement with training and methods modification
have also been reported [2,11]. Yet, detailed methods
used for microscopic endpoints in clinical trials are not
the norm, nor are quality control measures often in place
[7]. In addition, microscopists' proficiency is often poorly
defined. Based on these issues, outcomes of several clini-
cal trials have been in question in the two last decades
(unpublished observations).
Where microscopy is available in the clinical setting, phy-
sicians often treat patients despite negative blood film
reports, because of lack of confidence in the report [12].
False positive results may lead to failure to consider or
delay in the treatment of alternative life-threatening diag-
noses [1] and contribute to the cycle of ill health and
increasing poverty [13]. Accurate diagnosis in the clinical
setting is now more important than ever. Artemisinin-
based combinations (ACTs) overuse may result in more
rapid emergence of drug resistance. The relatively high
cost of these new drugs will make accurate diagnosis likely
to be cost effective [7].
This manuscript details problems, outlines pitfalls, and
provides solutions for successful, validated malaria micro-
scopy. These solutions will help provide valid results in
the clinical trial setting when microscopy is used as the
primary endpoint. The solutions presented are certainly
not unique to microscopy. Lessons learned, solutions pro-
posed, and the Centre of Excellence concept can be widely
adapted to improve clinical trials and health care world-
wide, especially in the developing world.
Case description
Malaria Diagnostics Centre of Excellence in Kisumu, 
Kenya
Primary mission, objectives and approach
The Malaria Diagnostics Centre of Excellence in Kisumu,
Kenya was established in March 2004. The primary mis-
sion for the Centre of Excellence is to ensure valid micro-
scopy when it is used to determine the primary endpoint
in clinical trials or to assess new diagnostic methods. This
mission is being accomplished through standardized and
quality training, consistent methods documented in
standard operating procedures (SOPs), a critically evalu-
ated rereading paradigm (for blood film reading), qualityMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
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control and assurance, and objective assessment and doc-
umentation of each microscopist's performance, in both
the formal testing setting and in everyday job perform-
ance.
Additional objectives are to train microscopists working
in the developing world in the clinical setting, to transfer
technology to host countries, to become internationally
recognized, and to establish partnerships with organiza-
tions with similar missions. Transfer of technology to host
countries is occurring through mentoring and motivating
host country leadership, training trainers for other loca-
tions, and transferring training materials to other centers.
The intention is to become internationally recognized
through training leaders, offering/advertising capability,
and by conducting, presenting, and publishing opera-
tional research results in areas of need.
Seven expert microscopists from four continents (Kenya
3, Peru 1, Indonesia 1, USA 1, and Thailand 1) were iden-
tified beginning in 2001. Standardized training was devel-
oped through their experience, review of relevant training
materials, and iterative improvement based on construc-
tive feedback and training results over two years. Useful
books and plates are available from WHO for purchase or
download [14,15].
Well-characterized slides were developed for formal slide
reading examinations. Slide examinations comprised well
characterized slides with low density parasitaemia of Plas-
modium falciparum, Plasmodium malariae, Plasmodium
ovale, true negatives, and serially diluted P. falciparum
slides (for counting). Training slide sets have been gener-
ated for each organization to have on site for on-going
training. Negative slides are prepared from non-exposed
people newly arriving to endemic areas to avoid the issue
of the low-parasite density healthy cases common in
malaria endemic areas. Fully validated species identifica-
tion and counting examinations are under development.
A written examination was developed and now consists of
65 multiple choice questions and a question bank to
assess microscopists' knowledge of key concepts and facts.
A digital picture test evaluation was also developed to
teach and evaluate microscopists' ability to correctly iden-
tify characteristics of artifact and of various growth stages
of each malaria species. PowerPoint presentations were
developed to train didactic and visual concepts necessary
for accurate microscopy. The test questions, pictures and
presentations have been iteratively improved over time.
Over the last four years, SOPs have been developed and
iteratively improved at the Kombewa research site near
Kisumu. These include SOP's for sample collection and
reception, slide preparation, buffer preparation, stain
preparation and staining of slides, slide reading, rereading
paradigm, slide storage, and quality control. These SOPs
are compared with the SOPs of the participants, and pro-
vided to course participants to take home.
Course resources, content and methodology
The venue for training is the Walter Reed Project Guest-
house lecture hall, located in Kisumu, Kenya. Laboratories
at the nearby sites are used for laboratory practicals.
Courses are conducted by experienced facilitators and sen-
ior microscopists. Currently, the Centre has three full-time
staff (Centre director/Course director, a microscopist, and
a database specialist), a part-time physician director, part-
time laboratory officer, and additional three to six expert
microscopists available for teaching. A twelve-day "long"
course was designed for first time training, and a four-day
"short" course is available as a refresher for those who per-
formed well in the long course.
Training targets malaria microscopists (laboratory tech-
nologists, researchers) from research and clinical labora-
tories. Entry requirements include at least a diploma or
certificate in medical laboratory technology and one year
of experience as a malaria microscopist. Attendees are cur-
rently required to be proficient in written and spoken Eng-
lish.
Essential equipment included 23 microscopes, four com-
puters, and two computer projectors. Fifteen high quality
power point presentations with lecture notes, a slide bank
of well-characterized malaria smears, a picture bank,
WHO Bench Aids for the Diagnosis of Malaria [14], WHO
Basic Malaria Microscopy yellow book [15], and SOPs are
used for training materials. Supplies for making slides are
available. Each visiting institution has been provided with
WHO training plates and Basic Malaria Yellow Book
[14,15], Walter Reed Project standard operating proce-
dures, and training sets of 50 slides. The intent of provid-
ing these materials is to continue to improve skills
between courses and in order to ultimately certify micro-
scopists.
Teaching methods consist of supervised laboratory practi-
cals, open laboratory time, lectures, group discussions/
presentations, demonstrations, and take home assign-
ments. Objective assessment include a pre- and post-train-
ing written test, positive-negative slide test, species
identification slide test, counting slide test, artifact and
species identification picture test, and slide preparation
practical. The agenda for the "long" course is presented in
Table 1. The "short" course agenda is presented in Table 2.
Objective evaluations
A written test comprising 65 questions was given as a pre-
and post-test. The following areas were covered: GoodMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
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Clinical Laboratory Practice/standard operating proce-
dures (32% of test questions), malaria parasite morphol-
ogy/stages (31%), slide preparation and staining (14%),
microscopy results interpretation (11%), microscope
care/knowledge (5%), general malaria knowledge (3%),
sensitivity/specificity calculation (2%), and density deter-
mination (2%). A practical slide reading examination of
30 slides was given before and after the course. Nineteen
slides were true negative, 11 were positive, and of the pos-
itive slides, nine were P. falciparum, one was P. ovale, and
one was P. malariae. The density range of the positives was
50–660 parasites/μl, with a mean of 220 and median of
142. Of the positive slides, one was 50 parasites/μl, five
were between 100–200 parasites/μl, and five were
between 201–660 parasites/μl.
Negative slides were collected in Jakarta and Bangkok
from healthy individuals in malaria free areas, who had
not traveled to malaria endemic areas or taken malaria
prophylaxis in the past two years or had malaria in the last
10 years. In Kenya, slides were collected from newly
arrived previously non-exposed individuals within five
days of arrival to Kenya. This was to ensure that the
donors were truly negative. Thirty-two percent of all true
negative smears were spiked with artifact (a mix of Staphy-
lococcus aureus and fungi) at varying densities (1/100 high
Table 1: Microscopy "long" course training agenda
Day Time Topic
1 9.00 – 9.30 Opening of the session
9.30 – 10.30 Introduction/Motivation/Goals of the course/Trials and tribulations
10.45 – 11.45 Clinical presentation of malaria
11.45 – 12.45 Qualities of a good microscopist
1.45 – 2.45 Microscope maintenance
2.45 – 3.45 Standard operating procedure (SOP) development
4.00 – 5.00 Multiple choice questions (MCQ) written pre-test
Homework Compare individual SOPs to Walter Reed Project SOPs. Note differences.
2 8.00 – 9.00 Good Clinical Laboratory Practice/Quality control
9.00 – 10.00 Photographic image pre-test
10.15 – 1.15 Slide reading pre-test (30 slides: 5 minutes each, 1 minute for passing the slide)
2.00 – 4.00 Counting pre-test (12 slides: 10 minutes each)
4.15 – 5.15 Review written test
Homework Review Bench Aids for the diagnosis of malaria infections
3 8.00 – 10.00 Slide preparation, review form for scoring slide quality
10.15 – 11.15 Malaria quality assurance & control
2.00 – 5.00 Laboratory – Slide preparation and staining
4 8.00 – 9.30 Species identification & groups' discussion
9.45 – 12.45 Laboratory – Species identification
1.45 – 2.45 Approach to mixed infections
2.45 – 3.45 Significance of false positives & negatives and counting
4.00 – 5.00 Review photographic image test with discussion
5 8.00 – 9.30 Artifacts, pseudo-parasites and the reality of false positives
9.45 – 12.00 Laboratory – Artifacts
1.00 – 3.45 Laboratory – Slide reading, address individual difficulties
4.00 – 5.00 SOPs – Groups' presentations and discussions
6, 7 Weekend Open microscopy laboratory
8 8.00 – 9.00 Malaria life cycle
9.00 – 10.00 Counting basics and techniques
10.15 – 12.00 Laboratory – Practice counting using Walter Reed Project SOP
1.00 – 4.30 Laboratory – Compare individual technique results to SOP technique results
4.45 – 5.15 Review day 1 to 5 microscopy
9 8.00 – 9.00 Low density infections
9.00 – 9.30 Cross contamination experiment
9.45 – 5.30 Laboratory – Individual laboratory in reference to the pretest scores
10 8.00 – 9.00 Malaria rereading paradigm
9.00 – 10.00 Review of the lectures
10.15 – 12.30 Questions and trouble points, Panel discussion
1.30 – 5.00 Laboratory – Review and scoring quality of blood slides
11 8.00 – 10.30 Slide reading post-test
10.45 – 11.45 Written post-test
11.00 – 12.15 Photographic image post-test
1.00 – 3.00 Counting post-test
3.00 – 5.00 Laboratory – Open microscopy and individual help
12 8.00 – 2.00 Go over tests and results, give out take-home training materialsMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
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power fields -2 per high power field). Negatives were val-
idated as negative by sampling criteria and by giving each
of the 209 participants the opportunity to challenge the
results with the Centre experts.
Sixty-six percent of positive smears were from the Malaria
Research and Reference Reagent Resource Center (MR4)
collection effort in Cambodia and contained P. falciparum
(not part of the available sets). MR4 positives were deter-
mined to be positive and species identified by two expert
readers in Indonesia with confirmation by three inde-
pendent expert readers at the Centre. These were supple-
mented by slides collected in Kenya containing P.
falciparum, P. malariae, and P. ovale. These were independ-
ently confirmed positive by one expert from Thailand and
three experts at the Centre. Positive smears were further
validated by giving each of the 209 participants the oppor-
tunity to challenge the results with the Centre experts
(asking staff to identify the parasites for them).
The slides used in practical slide reading examinations
were identical, but renumbered in the post-examination.
Participants were given five minutes per slide for reading.
One minute was provided between slides. They were
instructed to read 200 high power fields before calling the
smear negative. The presence or absence of parasites and
the species was recorded.
Ability to properly identify species and artifact was
assessed in a photographic image examination. The
images included 11 without and 19 with malaria para-
sites. Of those without parasites, various artifacts were
present. Images with parasites were distributed as follows:
five P. falciparum, four P. malariae, five P. ovale, two Plas-
modium vivax, and three mixed species with various stages
present.
A slide preparation practical emphasized correct sample
collection methods for making malaria blood smears,
smear preparation, preparation of stains, and individual
slide staining. Participants were then expected to make
smears using their own SOPs and the Walter Reed Project
SOPs. Five smears from each SOP were then assessed on a
standardized form, and the participant assigned a passing
or failing grade.
Interpretation of results, data management, and analysis
Written examination questions were scored as one point
each. Practical slide reading examinations were reported
as sensitivity, specificity, and species error. Sensitivity was
calculated as Sensitivity = (True Positives/[True Positives +
False Negatives]). Specificity was calculated as Specificity
= (True Negatives/[True Negatives + False Positives]). Data
were entered into, verified in, and calculations performed
with Microsoft Office Excel 2003. Further statistical anal-
yses were performed and tables constructed with SPSS
Table 2: Microscopy "short" course training agenda
Day Time Topic
1 8.00 – 9.00 Opening of the session
Introduction to malaria microscopy certification
9.00 – 11.15 Slide reading pre-test (30 slides: 5 minutes each, 1 minute for passing the slide)
11.30 – 12.30 Written pre-test
Species identification pre-test (20 slides: 5 minutes each, 1 minute for passing the
1.00 – 4.00 slide)
4.15 – 6.15 Counting pre-test (12 slides: 10 minutes each)
2 7.30 – 8.00 Review written pre-test
8.00 – 11.15 Laboratory – Review slide reading pre-test with discussion
11.30 – 12.15 Laboratory – Review species identification pre-test with discussion
1.00 – 4.00 Laboratory – Review counting pre-test with discussion
4.15 – 6.15 Laboratory – Individual laboratory help
3 7.30 – 8.00 Artifacts
8.00 – 9.45 Laboratory – Artifacts
10.00 – 10.30 Species identification
10.30 – 12.45 Laboratory – Species identification
1.30 – 2.00 Low density infections
2.00 – 4.00 Laboratory – Low density infections
4.15 – 4.45 Significance of false positive and negative results
4.45 – 6.30 Laboratory – Individual laboratory help, address difficulties
4 7.30 – 8.15 Written post-test
8.15 – 11.15 Slide reading post-test
11.30 – 1.15 Species identification post-test
1.45 – 4.45 Counting post-test
5.00 – 6.00 Awarding of certificatesMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
Page 6 of 9
(page number not for citation purposes)
14.0 for Windows. Pre- and post-test means were com-
pared with paired sample T-tests. Means were compared
with ANOVA, and proportions with Fisher's Exact Test (2-
sided). P values were not corrected for multiple compari-
sons.
Results
To date, 209 microscopists have participated from the fol-
lowing countries: Kenya (178), Uganda (10), Tanzania
(5), Rwanda (1), Burundi (1), Malawi (6), Cameroon (3),
Mali (2), Nigeria (2), and Thailand (1). One hundred and
fifty eight participants (76%) have been primarily
research and 51 (24%) have been primarily clinical. Lead-
ership/expertise has participated from Kenya (4), Uganda
(1), Nigeria (2), Mali (1), Cameroon (1), Zanzibar (2),
Thailand (1), Peru (1), USA (1), and Indonesia (1).
Data from the courses between July 2005 and January
2006 are reported here. These data include 77 participants
in the long course (including 10 who trained twice) and
23 participants in the short course (including five who
trained twice). Of these, 69% were conducting primarily
research. Participants were from Kenya (81), Tanzania
(5), Malawi (4), Rwanda (1), Burundi (1), Cameroon (2),
Nigeria (2), Mali (2), and Uganda (2). On a question-
naire, participants reported a mean (median) of years of
laboratory education 3 (3), years employed as a labora-
tory technician or technologist 9 (6), and years employed
as a malaria microscopist 5 (3). Twelve percent reported
that they were laboratory supervisors, 30% reported that
they had a malaria proficiency program in their labora-
tory, and 84% reported that they used SOPs in their labo-
ratory.
Pre- and post-training scores and percent improvement by
organizational group and course type from the most
recent participants are presented in Additional File 1.
With a mean specificity of 80% and range in mean by
organization on the pre-test of 66–91%, these data clearly
illustrate this is a serious problem in both the research and
clinical setting. Specificity improved substantially with
training (Additional File 1).
Thirty-two percent of all true negative smears were spiked
with artifact (mix Staphylococcus aureus with fungi at vary-
ing densities). On the pre-test, 26% of those spiked with
artifact were read as false positives, while 18% of those
not spiked were. On the post-test, 8% of those spiked with
artifact were read as false positives, while 6% of those not
spiked were. The slides with the highest density artifact
had higher rates of false positives. Spiked slides did not
appear to affect the species reported, except for a slightly
higher rate reported as P. vivax in the post-test. The false
positive smears reported as P. vivax and P. ovale increased
overall in comparing the pre-test with the post-test, while
the reporting of P. falciparum decreased.
The effect of parasitaemia on the false negative rate was
not as large as anticipated. The mean (median) densities
of those with false negatives on the pre-test were 174
(128) parasites/μl compared with 216 (142) parasites/μl
for the true positives. The densities were 133 (120) and
216 (142) parasites/μl for the false negatives and true pos-
itives on the post-test, respectively.
Short course participants were selected from those who
previously scored well in a long course. Comparison
between the long and short course scores in Additional
File 1 suggests that improved scores were maintained
from prior training, and that improvement continued
with additional training (Additional File 1).
The percentage of participants achieving sensitivity and
specificity cut points on final examination by organiza-
tion and course type is presented in Additional File 2.
Kenya research organizations have emphasized quality
microscopy for a number of years. This is reflected in the
percentage of individuals able to achieve acceptably high
cut points. For both research and clinical organizations,
this approach can select those qualified to be employed as
a microscopist and a given level of expertise. This
approach will be used to determine cut points for certifi-
cation at three levels of expertise.
CoE microscopy training appeared to substantially con-
tribute to obtaining a level of 90% sensitivity and specifi-
city on the pre-test, post-test, or both. Those that passed
neither had a mean (sd) of 0.14 (0.50) courses attended
previously, while those that passed just the post-test had a
mean of 0.5 (1.0) courses attended previously, and those
that passed both had attended 1.1 (1.6) course previously
(p = 0.004). Use of SOPs, having a malaria proficiency
program in the laboratory, and number of Good Clinical
Practice trials conducted appear to correlate with ability to
pass at a 90% sensitivity and specificity level (p = 0.014,
0.014, and p < 0.001, respectively). Years of training, years
of experience, being a laboratory supervisor, and Good
Clinical Practice courses did not appear to affect ability to
score well.
Discussion and evaluation
These data clearly illustrate that malaria microscopy is
problematic. The ultimate goal should be its replacement
by affordable, more robust diagnostic techniques, where
valid microscopy is not achievable. The Centre will help
ensure that microscopy is providing a valid "gold stand-
ard" comparator as these new tools continue to become
available and need evaluation for regulatory approval and
operational assessment. As long as microscopy is used toMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
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determine the primary endpoint in malaria prevention
and treatment trials, great lengths must be taken to ensure
that good products are not inadvertently discarded. A 1%
false positive rate with serially collected smears can under
estimate protective efficacy by 10–30% [8].
Many of the participants describe the training as a life
changing experience. They report they did not know they
were not accurately diagnosing malaria. After attaining
good test scores, they say they can now work with confi-
dence. They report it is not just malaria diagnosis that will
be improved, but all laboratory procedures they are
involved in. Certification is strongly desired.
The results are encouraging, but it remains to be seen if
improved results in the classroom setting translate to the
field, and if this concept is sustainable. Certification crite-
ria are currently being developed along with a plan to cer-
tify microscopists at a basic level from a limited number
of institutions in Kenya in the next twelve months. The
plan is to also offer an advanced level and expert level of
certification in the near future. Certificates will be valid for
two years. For a broader impact, the plan is to train train-
ers from other Centres to enable development of other
Centres of Excellence.
Government sector laboratory technicians are having
more difficulty achieving acceptable scores in the long
training course (Additional File 1). A modified and
lengthened course specific to their needs may be needed.
Changes in the policy and methods employed in this set-
ting are also likely necessary. RDTs are a logical alterna-
tive. However, RDT accuracy in the clinical setting of
holoendemic Africa must be determined. The simple pres-
ence or absence of parasitaemia may not distinguish
severe disease from malaria. The microscope will continue
to be needed for a variety of other diagnoses in the clinical
setting [16,17]. Accuracy and cost effectiveness of simpli-
fied malaria diagnosis (e.g. routine use of the thin smear)
should be assessed.
Errors with microscopy include false positives (specifi-
city), false negatives (sensitivity), species error (wrong
species or missed mixed infections), and counting error
[8,9,18-22]. Although not widely recognized, false posi-
tive smears are common with average microscopists
(Additional File 1). In the clinical setting, false positive
malaria smears may lead to no or delayed treatment for
the actual underlying disease, and therefore may also be a
cause of mortality [1,20]. In the research setting, false pos-
itive smears will lead to underestimated protective efficacy
in malaria prevention trials [8] and efficacy in treatment
trials. This may result in inappropriately categorizing a
vaccine or drug as not worth developing. It is suspected
that efficacy may have been underestimated in a variety of
trials conducted in the last 15 years. This series of suspi-
cions culminated in a trial where mefloquine's estimate of
"prophylactic efficacy" as a positive control in a Phase III
clinical trial was 1% (unpublished data). An investigation
revealed false positive malaria smears to be the cause. In
studies where a positive control is not employed (e.g.
malaria vaccine trials), such a problem may go completely
undetected.
Prestudy assessment of microscopists using a very limited
number of slides may help, but will not completely solve
the problem. For example, using blinded assessments of a
well-validated 15 slide test set, qualified microscopists
were identified for a recent malaria diagnostic pivotal
trial. Subsequently, internal QC mechanisms determined
that one senior microscopist still made errors in excess of
10%, requiring re-interpretation of hundreds of slides and
a substantial delay in completion of the analysis (RA Gas-
ser, personal communication).
False negative smears are expected at low parasite densi-
ties (e.g. < 100 parasites/μl) by chance [23]. Insufficient
reading time, poor smear quality, lack of motivation, and
poor equipment will also lead to false negative smears.
False negative smears will result in a lower than expected
attack rate if the study population is semi-immune and
does not become ill with low parasitaemia, but do not
adversely impact protective efficacy estimates in non-
immune or semi-immune populations (unless there is an
interaction between the test agent and immunity in semi-
immunes) [8]. False negative smears may lead to delayed
diagnosis and severe illness in non-immune study sub-
jects. This also results in clinicians ignoring the laboratory
results in malaria endemic areas [12].
Species errors are common with low density infections,
especially when only ring forms are seen [8,21]. Missed
mixed infections appear to be exceedingly common when
microscopy is compared with PCR [8,21,22]. Species
errors could have the effect of false positive or negative
smears if a species-specific endpoint is defined (e.g.
malaria vaccines).
Substantial variability in counting results is a common
problem. Counting errors may impact clinical trials if par-
asite density is an endpoint (e.g. malaria vaccines, early
malaria treatment failures). O'Meara and colleagues have
explored the factors affecting variability and assessed a
grid method for improving accuracy [24].
Several factors will lead to improved endpoints and confi-
dence in results in both the clinical trial and clinical set-
ting. Suggestions are as follows for clinical trial setting:
proficiency training and testing leading to certification of
microscopists at varying levels of expertise, a rereadingMalaria Journal 2007, 6:79 http://www.malariajournal.com/content/6/1/79
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paradigm specifically designed for the situation, SOPs,
quality control and assurance, laboratory standards, and
reporting guidelines.
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